GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FDPS, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.4508 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FDPS, FUT7, GLO1, HSD17B3, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
9.92914 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
8.60535 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.56692 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
8.53684 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TYR |
8.35442 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
8.05271 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
8.04268 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, HCAR2, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
7.99711 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
7.77514 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.73113 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, SRC, TYR |
7.14294 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, HSD17B3, NQO2, PTGS1, PTGS2, TYR, XDH |
6.8221 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.71899 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD3, ESR1, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SRC, XDH |
6.47358 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, PTGS2, SRC, TYR |
6.42362 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FDPS, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.4081 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRA, FLT3, GPER1, PTGS2, SRC, TYR |
6.4081 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, PPARA, PTGS2, SRC |
6.04259 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TYR |
6.04219 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.99008 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, CDC25B, CSNK2A1, CYP1B1, DRD3, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
5.92741 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, PIK3CA, PPARA, SRC, TYR |
5.91281 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
5.91281 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, FLT3, GPER1, HCAR2, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.90196 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, FLT3, GPER1, HCAR2, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.87833 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.71771 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
5.70762 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, PTGS2, SRC |
5.52348 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.51576 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
5.46519 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
5.4583 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, HSD17B3, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, TOP2A, TYR |
5.23789 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, HSD17B2, HSD17B3, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.23789 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FDPS, FLT3, GPER1, HCAR2, PPARA, PTGS2, SRC |
5.18981 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
5.16244 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC |
5.15515 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
5.14063 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
5.07867 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
4.89616 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
4.80343 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.76325 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3 |
4.76325 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD3, FABP3, PPARA |
4.66457 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD3, ESR1, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.60894 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD3, GPER1, HCAR2, KDR, PIK3CB, PTGS2, SRC |
4.12527 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, AXL, CYP1B1, FLT3, GPER1, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.0969 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD3, GPER1, MET, PIK3CA, PIK3CB, SRC, XDH |
4.03452 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR |
4.00516 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
4.00262 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
4.00262 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.95883 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, AR, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, SRC |
3.92193 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
3.92193 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.92193 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, CSNK2A1, DRD3, ESR1, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
3.8803 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CYP1B1, ESR1, GPER1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, SRC |
3.87085 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD3, GPER1, HCAR2, PIK3CB, PTGS2 |
3.86526 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
3.84766 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, DRD3, FLT3, GPER1, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.83492 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, CA12, CA2, CA7, DRD3, ESR1, FABP3, FABP4, FLT3, GPER1, MET, PIK3CA, PIK3CB, SRC |
3.78825 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
3.75309 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, AR, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, PIK3CA, PTGS2, SRC |
3.72457 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.66822 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
3.66822 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.66716 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD3, FABP3, PPARA |
3.66179 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, DRD3, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.62345 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, ESR1, ESR2, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.62118 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
3.62118 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS |
3.62118 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
3.62054 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.61462 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.59411 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.59411 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, ESR1, ESR2, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.5515 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.5515 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, PTGS2, SRC |
3.52774 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, DRD3, ESRRA, FABP4, FLT3, GPER1, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.5093 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, NQO2, PTGS1 |
3.5093 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, AR, CDC25B, ESRRB, FLT3, GPER1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.43283 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, SRC, TOP2A |
3.35596 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PPARA, PTGS1, PTGS2 |
3.35596 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
3.35596 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
3.31871 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, AR, CDC25B, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.30496 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS |
3.30231 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.30125 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
3.28948 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.24503 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD3, GPER1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.22069 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.20297 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.17411 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AR, AURKB, CDC25B, CSNK2A1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
3.16134 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD3, GPER1, KDR, SRC |
3.1589 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.11614 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD3, ESR1, GPER1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.11173 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.10383 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.09631 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR |
3.04095 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, DRD3, FDPS, HSD17B3, TYR |
3.03943 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
3.03411 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
3.01127 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DRD3, ESR1, ESRRB, FABP4, GPER1, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
3.0085 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, FLT3, GPER1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.98972 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.93881 |
[BP] GO:0008217 |
None
|
ADORA1, AR, DRD3, PPARA, PTGS1, PTGS2 |
2.93881 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AR, AURKB, CDC25B, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.92516 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.89936 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD3, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
2.89936 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AR, AURKB, CDC25B, CSNK2A1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.8973 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.89467 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AR, AURKB, CDC25B, CSNK2A1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.891 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.84935 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.81975 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.80291 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.78244 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.77771 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.74235 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GPER1, IGF1R, PPARA, PTGS2, SRC |
2.73896 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AR, AURKB, CSNK2A1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SRC, XDH |
2.72285 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AR, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, MMP2, MMP9, PTGS2, SRC, TOP2A |
2.68434 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.66477 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, PTGS2, SRC |
2.65459 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD3, FABP3, KDR, PTGS2, SRC |
2.65269 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.6308 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.62174 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.61634 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.60163 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, FABP4, FLT3, GPER1, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
2.57425 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.56255 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, SRC |
2.56081 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.56081 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.55558 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.54912 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.49482 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.46056 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.45895 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.45895 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.45895 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, AR, FLT3, GPER1, KDR, PIK3CB, PTPN1, SRC, XDH |
2.44938 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD3, ESR1, PPARA, SRC, TOP2A |
2.44682 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.4157 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD3, ESR1, FABP3, FABP4, GPER1, MET, PIK3CA, PIK3CB |
2.41062 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.39953 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.39387 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD3, KDR, SRC |
2.38973 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.38973 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.38155 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.38155 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.38155 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.38155 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3 |
2.37674 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, GPER1, PTGS2 |
2.36857 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.35832 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.35281 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.35281 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
2.34503 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.34503 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD3, GPER1, PTGS2 |
2.34074 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD3, GPER1, PTGS2 |
2.34074 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34074 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, PTGS2 |
2.33648 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, CYP19A1, DRD3, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.3362 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.33576 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, GPER1, MMP9, PTGS2, SRC, XDH |
2.32791 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.32791 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD3, ESR1, ESR2, ESRRA, FABP4, FLT3, GPER1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
2.31427 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, GPER1, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.29718 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29718 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, AR, ESR1, FLT3, GPER1, IGF1R, MMP2, PTGS2, SRC |
2.29552 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, GPER1, MMP2, MMP9, PTGS2 |
2.28866 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AR, AURKB, CDC25B, CSNK2A1, DRD3, ESR1, FABP4, FLT3, GPER1, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.27604 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25383 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.25383 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25383 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25383 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25383 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.22619 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, GPER1, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.21973 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, GPER1, PTGS2, SRC |
2.21333 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.20139 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, FDPS, HSD17B3, PTGS1, PTGS2 |
2.19785 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, AR, FLT3, GPER1, IGF1R, KDR, PIK3CB, PTPN1, SRC, XDH |
2.14687 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, AR, CDC25B, FLT3, GPER1, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.1101 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.09882 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.07652 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, GPER1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A |
2.06973 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.06219 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.06219 |
[BP] GO:0030263 |
None
|
GPER1, TOP2A |
2.06219 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, GPER1, MMP9, PTGS2, SRC, XDH |
2.05793 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.03971 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.00092 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, KDR, MET, PPARA, PTGS2, SRC, TOP2A |
2.00092 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, GPER1, HCAR2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
2.00092 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AR, AURKB, CA1, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HSD17B1, HSD17B2, HSD17B3, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
2.91096 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AOX1, APEX1, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HSD17B3, IGF1R, KDR, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SHBG, SRC, TOP2A, TYR, XDH |
2.71584 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, CA4, CYP19A1, CYP2D6, FLT3, GPER1, HSD17B3, KDR, PTGS2, PTPN1, XDH |
2.41951 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AOX1, APEX1, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPER1, HSD17B3, IGF1R, KDR, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SHBG, SRC, TOP2A, TYR, XDH |
1.9608 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.93239 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, TYR, XDH |
15.6532 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
12.3741 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
11.2352 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
10.2257 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.40627 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1 |
8.22382 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, HSD17B3, NQO2, PTGS1, PTGS2, TYR, XDH |
8.04879 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.04268 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, TOP2A, TYR, XDH |
7.88999 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.8221 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.8221 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, TOP2A, TYR, XDH |
6.8221 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, SHBG |
6.66357 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, GLO1 |
6.65429 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.36171 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
5.50911 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.4199 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, NQO2, SHBG |
5.40943 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
5.29605 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.1821 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, TYR |
4.97192 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
4.97192 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TOP2A |
4.95626 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
4.89158 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.13903 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.05658 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.05658 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
3.86526 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HSD17B1, PPARA, SHBG |
3.61532 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.61462 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.52407 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA |
3.17411 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.09631 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.0864 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.84935 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.84935 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.8308 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.80361 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, GPER1, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SHBG, SRC, TOP2A, XDH |
2.77191 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA |
2.63086 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.55558 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA |
2.49324 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.44656 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.41051 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.40067 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, HSD17B3 |
2.38973 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25383 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25383 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HCAR2, IGF1R, KDR, MET, PPARA |
2.24907 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.19785 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.11932 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD17B1, HSD17B2, HSD17B3 |
2.04075 |